Skip to main content
Premium Trial:

Request an Annual Quote

Illumina to Market GenoLogics' Geneus LIMS

Premium

GenoLogics said this week that Illumina will market a version of its Geneus Laboratory Information Management System software that is preconfigured to handle data from Illumina's HiSeq and Genome Analyzer sequencing platforms and TruSeq sample preparation kits.

The Canadian firm said that its software will enable Illumina users to automate workflows, track library preparations and instrument runs, and prepare basic reports within weeks rather than months.

GenoLogics CEO Michael Ball noted that the combined efforts of the two firms will enable sequencing laboratories to deploy instrumentation and data management tools simultaneously, thus addressing a data-related bottleneck highlighted in a recent survey conducted by JP Morgan.

GenoLogics noted that 63 percent of NGS laboratory directors who participated in the survey identified data storage, data management, and informatics as the "biggest hurdles to expanding next-generation sequencing."

Ball noted that the current arrangement follows an earlier preferred partner agreement between the two companies that made it possible for his firm to develop a version of the LIMS software that is "complementary" to Illumina's sequencing platforms and sample prep kits.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.